Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease – Data from the multicenter CEDATA-GPGE registry study
Merle Claßen, Jan de Laffolie. Martin Claßen, Alexander Schnell, Keywan Sohrabi, André Hoerning on behalf of the CEDATA-GPGE® Study Group Front. […]